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Background The evaluation of neuromuscular diseases includes detailed clinical
assessment, blood testing, electrodiagnostic studies (EDS), biopsy, and genetic tests.
EDS alone cannot provide a specific diagnosis. Further testing in the form of genetic
tests or muscle biopsy (MB) is required.
Objective The objective of the study is to evaluate the yield of MB in patients with
findings of myopathy on electrodiagnostic testing and assess the factors affecting an
abnormal biopsy outcome.
Methods Electromyography (EMG)/nerve conduction studies (NCS) performed for
suspected myopathy over 5 years from 2011 to 2016, at the neurophysiology department of a tertiary care center in Pakistan, were reviewed. Based on inclusion criteria,
records of 58 patients were retrospectively reviewed.
Results After an EMG/NCS diagnosis of myopathy, the frequency of MB testing was
only 10.1%. The median age of patients was 26.5 years. The clinically suspected diagnosis was categorized into hereditary myopathy (n = 15, 25.9%) and acquired myopathy (n = 18, 31%). The positive predictive value of EMG is 77.2%. Twenty-eight (48.2%)
patients had abnormal MB whereas 20 (34.4%) revealed normal findings. Factors significantly influencing an abnormal outcome of biopsy included moderate-to-severe
elevation of creatine kinase (>2,000 U/L), presence of denervation changes, and severe
myopathy on EMG.
Conclusion Even though the overall yield of MB testing may not be very high in our
setting due to the unavailability of special techniques and expertise, certain factors
can help to improve the diagnostic yield. Clinicians should encourage MB testing,
especially in cases with strong clinical, laboratory and electrodiagnostic suspicion, and
absence of genetic testing for suspected myopathy.

Introduction
Accurate diagnosis of neuromuscular disorders (NMDs) is
based on a detailed clinical assessment, laboratory and electrodiagnostic testing, histological examination of tissue, and
genetic tests.1-3 Nerve conduction studies (NCS) and electromyography (EMG) are valuable in localizing and assessing
the severity of NMDs, identifying the distribution of involved
muscles, and the appropriate muscle to biopsy, and may be
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useful for assessing disease progression. While NCS/EMG can
suggest a myopathic process, it is seldom useful to provide
a specific diagnosis, may be technically difficult, especially
in children and may be subject to operator bias. Therefore,
further testing in the form of muscle biopsy (MB) or genetic
testing is required.4,5
MB testing is dependent on proper sampling technique/
handling, muscle selection, expertise of the pathologist,
availability of numerous stains, and electron microscopic
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evaluation.6,7 In Pakistan, we face limitations in all of these
steps. As a result, clinicians have a tendency to rely on clinical
judgment and avoid an MB to spare patient time, pain, and
money.
With these limitations, data on the diagnostic yield of
MB in myopathic disorders are lacking from Pakistan. We
planned this study to determine the yield of MB in clinically,
and EMG diagnosed cases of myopathy.

Methods
After approval from Institutional Ethics Review Committee, 1,290 electrodiagnostic studies (EDS) performed for
suspected myopathy over 5 years from 2011 to 2016, at the
neurophysiology department of a large private tertiary care
university hospital of Pakistan, were reviewed. Of these, 570
studies showed evidence of myopathy which was based on
short-mean duration and short amplitude of motor units in
two or more muscles. Only 58 of these underwent MB testing
in the same hospital and were included in the study. Medical
records of these selected cases were retrospectively reviewed
for demographic, clinical, laboratory, and histopathological
data.
Clinical data included the suspected diagnosis which was
categorized into hereditary or acquired myopathy, rate of
progression of myopathy, and the predominant distribution
of weakness.
Electrodiagnostic variables included the presence of spontaneous activity (positive sharp waves and fibrillation potentials) and the severity of myopathy on needle examination.
The latter was categorized into mild-to-moderate and severe
myopathy based on the electromyographer’s assessment.
Motor units of short duration and amplitude intermixed with
normal looking motor units were categorized into mild–
moderate category, whereas severe category included only
myopathic units without any evidence of intermixed normal
units.
MB data were classified into three main groups, negative
for myopathy (normal), positive (inflammatory or dystrophic), and inconclusive.
Data were compiled and analyzed using IBM SPSS Statistics for Windows Version 19.0 (IBM Corp., Armonk, NY). The
histopathological diagnosis of muscle biopsies was compared
with the clinically suspected diagnosis, EMG, and serological
findings using the Chi-square test.

Results
Of the 570 patients that had a positive EMG for myopathy
during the 5 years’ study, only 58 underwent MB testing (10.1%). Patients of all age groups were enrolled in
the study with a median age of 26.5 years (interquartile
range = 14–42.2).
Fifteen cases were clinically suspected of having a hereditary myopathy, while 18 were suspected to have an acquired
myopathy, which included inflammatory myopathy in 17 and
critical illness myopathy in one patient. Muscle enzymes,
that is, creatine kinase (CK) and aldolase levels were checked
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in 48 and 21 patients, respectively. About 37.5% had moderate-to-severe elevation of CK (>2,000 U/L). On NCS/EMG,
severe myopathy was noted in 29 (50%) of cases, and denervation changes suggestive of a necrotizing myopathy were
seen in 35 (60.3%) patients. One patient showed myotonic
discharges on EMG with mild-to-moderate severity of myopathy electrically. Histopathological analysis of MB turned out
to be normal in this patient (►Table 1).
Out of 58 patients with myopathic findings on electrodiagnostic testing who had MB, 28 (48.2%) had an abnormal biopsy result. Sixteen (57.14%) of the abnormal muscle biopsies
showed inflammatory pathology, 11 (39.2%) had dystrophic
biopsies of which 3 were dystrophic other than dystrophinopathy and 1 patient showed evidence of steroid-induced
myopathy (►Fig. 1).
Certain findings on electrodiagnostic tests may have an
influence on the outcome of MB (►Table 2). Out of the 22
patients with severe myopathy on EMG, 17 (77.3%) revealed
an abnormal MB, whereas of those with a mild to moderate
myogenic needle examination, 15 (57.7%) showed normal
muscle histopathology. This difference was statistically significant (p = 0.02). In addition, the presence of fibrillation
potentials and positive sharp waves correlated with a positive MB in 20 (71.4%) cases (p = 0.04). Similarly, the degree of
elevation of CK correlated significantly with the biopsy result
as moderate-to-severe elevation of CK was noted in 75% (12)
of abnormal biopsies (p = 0.02).
Of the 15 patients suspected of a hereditary myopathy, 6 (40%) had dystrophic muscle biopsies. On the other
hand, 12 out of 18 patients (66.7%) with an acquired myopathy yielded a biopsy outcome correlating with the clinical
suspicion. A significant number of muscle biopsies revealed
normal histopathology when the clinical diagnosis was not
specified, that is, two out of four (50%) or not available (11
out of 20, 55%). Overall, the correlation of clinically suspected
diagnosis with the biopsy result did show statistical significance (p = 0.002; ►Table 3).
The severity of myopathy on needle examination, the
presence of denervation changes, and the severity of CK
elevation, although predictive of an overall positive biopsy
result, were not very useful in terms of predicting a specific
histopathological diagnosis and were found in both dystrophic and inflammatory muscle biopsies (p = 0.05, 0.07, and
0.14, respectively; ►Table 3).

Discussion
Genetic testing and/or histopathological analysis of muscles are considered to be definitive tests for the diagnosis of
myopathic disorders with clinical, serological, and electrodiagnostic data providing supporting evidence. Given the limited availability of genetic testing in Pakistan, much of the
reliance is on clinical and electrodiagnostic evaluations. MB
testing although available in certain tertiary care centers is
poorly relied on by clinicians due to the lack of expertise and
special techniques. This is evident from the finding that out
of a total of 570 EMG studies which showed myopathic process, only 10.1% underwent MB. Even though we were not
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Table 1 Characteristics of the study population
Characteristics

Table 1 (continued)

n (%)

Characteristics

Age (y)

n (%)

Biopsy site

Mean

30.6 ± 1.96

Deltoid

21 (26.2)

Median (IQR)

26.5.(14–44.2)

Biceps brachii

18 (31)

Quadriceps femoris

15 (25.9)

Gastrocnemius

1 (1.7)

Gender
Male

33 (56.9)

Female

25 (43.1)

Abbreviations: CK, creatine kinase; EMG, electromyography; ESR,
erythrocyte sedimentation rate; IQR, interquartile range.
a
Data available for 48 patients.
b
Data available for 21 patients.
c
Data available for 31 patients.

Rate of progression
Rapid

5 (8.6)

Moderate

21 (36.2)

Slow

22 (37.9)

Unknown

10 (17.2)

Distribution of weakness
Predominant proximal

41 (70.6)

Predominant distal

9 (15.5)

Not available

8 (13.8)

EMG denervation

35 (60.3)

EMG severity
Mild

11 (19)

Moderate

18 (31)

Severe

29 (50)

EMG distribution
Generalized

27 (46.6)

Proximal

30 (51.7)

Distal

1 (1.7)

Serum CKa
Mean

2,063.08 ± 3,050.1

Median (IQR)

700.5.(141–2,502.2)

Normal (<200)

14 (24.1)

Mild (201–2,000)

16 (27.6)

Moderate-to-severe
(>2,000)

18 (31.0)

Serum aldolaseb
Mean

19.9 ± 22.9

Median (IQR)

10.(5.1–28.7)

ESR
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c

Mean

29.8 ± 30.5

Median (IQR)

21.(5–47)

Clinical diagnosis
Hereditary myopathy

15 (25.9)

Acquired myopathy

18 (31)

Not specified

5 (8.6)

Not available

20 (34.5)

(continued)

able to account for those patients who may have had an MB
from a different center, the frequency of MB testing in our
setting still appears to be very low. This study was performed
to estimate the overall yield of MB, even with above-mentioned limitations, in our setup.
We found that out of a total of 58 muscle biopsies done
during 2011 to 2016, 28 (48.27%) provided a positive result
of which 19% were dystrophinopathy, 27.6% were inflammatory, and one showed findings of steroid-induced myopathy.
The positive diagnostic yield of MB testing reported in different studies ranges from 60 to 93%.4,5,8-10
The relatively low rate of positive results on the histopathological analysis in our study can be because of numerous factors. Improper muscle selection for biopsy, inadequate
amount of the biopsy specimen, lack of use of special stains,
and electron microscopic examination, limited experience
of the observer or very advanced stage at the time of biopsy
testing may contribute to the biopsy outcomes.6,7
Ten cases (17.2%) showed minimal findings for a definitive
pathological diagnosis. This is almost similar to the finding
noted by Rabie et al, where 5 out of the 55 patients showed
nonspecific biopsy findings despite a myopathic EMG.4
Advanced disease stage, biopsy testing after treatment initiation, or inadequate sampling technique may contribute to
these inconclusive results.
In 34.4%, MB turned out to be normal despite the electrodiagnostic evidence of a myopathy. Of these, nine had a
strong clinical suspicion of myopathy, five had evidence of
a severe myopathy on EMG, eight had active denervation
changes on EMG, and eight had elevated muscle enzyme, CK
(four had CK > 2,000 U/L). These findings raise the possibility
of a false-negative MB in these cases which can be because of
the factors mentioned above.
In our study, the positive predictive value of EMG was
found to be 77.2%. The sensitivity of EMG for diagnosing
myopathy ranges between 58 and 90% in different studies.
These figures may vary among different muscles being tested, at different disease stages and in different age groups. It,
however, tends to be lower (14–75%) in children with age <2
years.2,4,9,11 This wide variation of sensitivity of EMG among
different studies probably suggests that evaluation of motor
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Fig. 1 Histopathological outcome of muscle biopsy (%).

Table 2 Comparison of muscle biopsy findings with clinical, laboratory, and electrodiagnostic dataa
Data

Positive biopsy (n = 28)
n (%)

Negative biopsy (n = 20)
n (%)

Yes

20 (71.4)

8 (28.6)

No

8 (40)

12 (60)

Normal <200

3 (25)

9 (75)

Mild 201–2000

8 (66.7)

4 (33.3)

Moderate-to-severe > 001

12 (75)

4 (25)

Mild to moderate

11 (42.3)

15 (57.7)

Severe

17 (77.3)

5 (22.7)

Hereditary

7 (63.6)

4 (36.4)

Acquired

13 (81.2)

3 (18.8)

Not specified

2 (50)

2 (50)

Not available

6 (35.3)

11 (64.7)

p-Value

EMG denervation
0.04

Serum CK
0.02

EMG severity
0.02

Clinical diagnosis

0.06

Abbreviations: CK, creatine kinase; EMG, electromyography.
a
Inconclusive biopsies were not included in this analysis.

units on needle electrode examination is a subjective assessment of the operator and is subject to interobserver variability with both false-positive and false-negative findings. This
is, therefore, the reason that the diagnostic accuracy of EMG
for myopathy is reported to be around 60%.2 As EMG testing
can have false-positive results, therefore, a negative MB in
cases of mild or even moderate myopathy on EMG testing
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should be interpreted in accordance with other clinical and
serological evidence.

Conclusion
Based on the findings from this study, it can be suggested that, even though the overall yield of MB testing may be
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Table 3 Comparison of biopsy findings with clinical, laboratory, and electrodiagnostic dataa
Data

Inconclusive (n = 10)
n (%)

Inflammatory (n = 16)
n (%)

Dystrophic (n = 11)
n (%)

Normal (n = 20)
n (%)

Mild to moderate

3 (10.3)

6 (20.7)

5 (17.2)

15 (51.7)

Severe

7 (25)

10 (35.7)

6 (21.4)

5 (17.9)

Yes

7 (20.6)

13 (38.2)

6 (17.6)

8 (23.5)

No

3 (13)

3 (13)

5 (21.7)

12 (52.2)

Normal <200

2 (14.3)

2 (14.3)

1 (7.1)

9 (64.3)

Mild 201–2000

4 (26.7)

5 (33.3)

2 (13.3)

4 (26.7)

Moderate to
severe >2001

2 (11.1)

7 (38.9)

5 (27.8)

4 (22.2)

Hereditary

4 (26.7)

1 (6.7)

6 (40)

4 (26.7)

Acquired

2 (11.2)

12 (66.7)

1 (5.6)

3 (16.7)

Not specified

1 (25)

1 (25)

0

2 (50)

Not available

3 (15)

2 (10)

4 (20)

11 (55)

p-Value

EMG severity
0.05

EMG denervation
0.07

Serum CK

0.14

Clinical diagnosis

0.002

Abbreviations: CK, creatine kinase; EMG, electromyography.
a
One patient with steroid-induced myopathy was excluded from this analysis as it was a separate category.

lower as compared to other countries, certain factors can
help to improve the yield. They include moderate-to-severe
CK elevation, severe myopathy, and presence of fibrillation
potential/positive sharp waves on EMG. The suspected clinical diagnosis may also have a significant impact. Clinicians
should encourage MB testing, especially in cases with a
strong clinical, laboratory, and electrodiagnostic suspicion
and absence of genetic testing for the suspected myopathy.
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